Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Lababidi (Oxford, United Kingdom), J. Cane (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom). Interferon responses are dysfunctional in the epithelium of COPD Patients. 1068

Member's Comments

No comment yet.

Related content which might interest you: Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-? Source: ERJ Open Res, 3 (3) 00008-2017; 10.1183/23120541.00008-2017 Year: 2017 Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Mechanisms of impaired anti-bacterial Th1 responses in patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Impact of cytokines on endothelium in COPD patients Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients Source: International Congress 2014 – Translational studies in COPD Year: 2014 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Cytokine regulation of local and systemic inflammation in COPD patients Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Altered P2 receptor expression profile in sputum cells of patients with COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Smoking and airway inflammation in asymptomatic subjects and in patients with chronic airway disease Source: Eur Respir J 2002; 20: Suppl. 38, 90s Year: 2002 Cytokine regulation of the chronicle inflammation of bronchial asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 590s Year: 2005 Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients Source: International Congress 2014 – Translational studies in COPD Year: 2014 Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors Source: International Congress 2014 – Asthma and COPD management Year: 2014 Antiviral biomarkers are upregulated in sputum cells following administration of inhaled interferon beta to COPD patients Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Study of the inflammatory phenotype of asthmatic patients with bronchiectasis Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013